An adaptive drug-releasing contact lens for personalized treatment of ocular infections and injuries
Journal of Controlled Release · 2024-05 · 369 · 114-127
DOI: 10.1016/j.jconrel.2024.03.040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2024-05. Verfasst von Rong Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, PR China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Keratitis, Levofloxacin, Diclofenac. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
This research introduces an innovative solution to address the challenges of bacterial keratitis and alkali burns. Current treatments for bacterial keratitis and alkali burns rely on the frequent use of antibiotics and anti-inflammatory eye drops. However, these approaches suffer from poor bioavailability and fluctuating concentrations, leading to limited efficacy and potential drug resistance. Our approach presents an adaptive drug-releasing contact lens responsive to reactive oxygen species (ROS) at ocular inflammation sites, synchronously releasing Levofloxacin and Diclofenac. During storage, minimal drug release occurred, but over 7 days of wear, the lens maintained a continuous, customizable drug release rate based on disease severity. This contact lens had strong antibacterial activity and biofilm prevention, effectively treating bacterial keratitis. When combined with autologous serum, this hydrophilic, flexible lens aids corneal epithelial regeneration, reducing irritation and promoting healing. In summary, this ROS-responsive drug-releasing contact lens combines antibacterial and anti-inflammatory effects, offering a promising solution for bacterial keratitis and alkali burns.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, PR China.
- School of Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, PR China.
- School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, PR China. Electronic address: nixianpu126@126.com.
- Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, PR China. Electronic address: pharm305@126.com.
- Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, PR China. Electronic address: pharmzy@163.com.
Zitieren
APA
Sun, R., Zhang, J., Chen, X., Deng, Y., Gou, J., Yin, T., He, H., Tang, X., Ni, X., Yang, L., & Zhang, Y. (2024). An adaptive drug-releasing contact lens for personalized treatment of ocular infections and injuries. Journal of Controlled Release, 369, 114-127. https://doi.org/10.1016/j.jconrel.2024.03.040
Vancouver
Sun R, Zhang J, Chen X, Deng Y, Gou J, Yin T, et al. An adaptive drug-releasing contact lens for personalized treatment of ocular infections and injuries. Journal of Controlled Release. 2024;369:114-127. doi:10.1016/j.jconrel.2024.03.040
BibTeX
@article{Sun2024,
author = {Sun, Rong and Zhang, Jie and Chen, Xi and Deng, Yaxin and Gou, Jingxin and Yin, Tian and He, Haibing and Tang, Xing and Ni, Xianpu and Yang, Li and Zhang, Yu},
title = {An adaptive drug-releasing contact lens for personalized treatment of ocular infections and injuries},
journal = {Journal of Controlled Release},
year = {2024},
volume = {369},
pages = {114--127},
doi = {10.1016/j.jconrel.2024.03.040}
}
EUVIMED